Lonza Inc. Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of Ipsen (IPN.PA)'s Increlex
5/1/2013 8:20:36 AM
More...
|
Another Biosimilar Product Setback? Lonza Inc. Rethinking Pact With Teva Pharmaceutical Industries Limited (TEVA)
4/1/2013 8:28:26 AM
More...
|
Lonza Inc., Hyglos Reach on Global Settlement Agreement for Endotoxin Detection Patents
3/20/2013 9:27:49 AM
More...
|
BaroFold, Inc. and Lonza Inc. Announce a Technology Evaluation Agreement for PreEMT™, a High Pressure Protein Refolding Technology
1/16/2013 9:12:19 AM
More...
|
Lonza Inc. to Invest $15.1 Million to Expand Antibody Drug Conjugate
1/9/2013 8:04:08 AM
More...
|
Lonza Inc. and Celladon Corporation Announce Manufacturing Agreement for MYDICAR®
10/2/2012 10:56:33 AM
More...
|
Lonza Inc. and BioWa Sign License Agreements with FivePrime Therapeutics, Inc. for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development
6/13/2012 10:25:54 AM
More...
|
Avalanche Biotechnologies and Lonza Inc. Announce Global Manufacturing Collaboration for Adeno-associated Viral Vectors for Gene Therapy
5/16/2012 9:33:33 AM
More...
|
Lonza Inc. and Agennix AG Sign Development and Manufacturing Deal for Production of Talactoferrin
4/12/2012 9:23:17 AM
More...
|
Immutep S.A. and Lonza Inc. Sign Agreement for Cell Line Selection, Cell Banking and Process Development of ImmuFact(R) IMP321
4/10/2012 11:23:20 AM
More...
|
|